CanSino Biologics Inc.’s (HKG:6185) stock price dropped 9.0% last week; individual investors would not be happy

CanSino Biologics Inc.’s (HKG:6185) stock price dropped 9.0% last week; individual investors would not be happy

29 Sep Stock Analysis

Key Insights

CanSino Biologics’ significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public
A total of 25 investors have a majority stake in the company with 42% ownership
Recent sales by insiders

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10bn in marketcap – there is still time to get in early.

A look at the shareholders of CanSino Biologics Inc. (HKG:6185) can tell us which group is most powerful. We can see that individual investors own the lion’s share in the company with 57% ownership. That is, the group stands to benefit the most if the stock…

Tags: